SCHEMBL4191585

SCHEMBL4191585

COC(=O)NC[C@H](CC(=O)NCCc1ccccc1)CC(C)C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.52
KMT2A Q03164 2/20 0.52
ALDH1A1 P00352 1/20 0.52
ANPEP P15144 1/20 0.50
POLB P06746 1/20 0.47
TAAR1 Q96RJ0 3/20 0.46
LMNA P02545 2/20 0.45
NPC1 O15118 1/20 0.45
GAA P10253 1/20 0.45
RAB9A P51151 1/20 0.45
PKM P14618 1/20 0.45
MAPT P10636 1/20 0.45
RECQL P46063 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
HDAC3 O15379 1/20 0.44
HDAC4 P56524 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC7 Q8WUI4 1/20 0.44
HDAC2 Q92769 1/20 0.44
HDAC10 Q969S8 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18426210 0.83 KMT2A (0.58) HPGDKMT2AALDH1A1ANPEPPOLB
SCHEMBL2013100 0.82 KMT2A (0.57) HPGDKMT2AALDH1A1ANPEPPOLB
SCHEMBL4186748 0.81 KMT2A (0.56) HPGDKMT2AALDH1A1ANPEPPOLB
SCHEMBL4184855 0.81 KMT2A (0.56) HPGDKMT2AALDH1A1ANPEPPOLB
SCHEMBL2014475 0.80 HDAC3 (0.55) HPGDKMT2AALDH1A1ANPEPPOLB
SCHEMBL338943 0.79 GPR139 (0.47) HPGDKMT2AALDH1A1POLBLMNA
SCHEMBL11931667 0.79 GPR139 (0.47) HPGDKMT2AALDH1A1POLBLMNA
SCHEMBL338031 0.79 GPR139 (0.47) HPGDKMT2AALDH1A1POLBLMNA
SCHEMBL338032 0.79 GPR139 (0.47) HPGDKMT2AALDH1A1POLBLMNA
SCHEMBL6045130 0.78 KMT2A (0.79) HPGDKMT2AALDH1A1ANPEPPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017019791-A1 SYNTHESIS OF (S)-PREGABALIN TEVA PHARMACEUTICALS INTERNATIONAL GMBH (CH) 2017-02-02 WO disclosed
EP-2021318-A2 SYNTHESIS OF (S)-(+)-3-(AMINOMETHYL)-5-METHYL HEXANOIC ACID Teva Pharmaceutical Industries Ltd. (IL) 2009-02-11 EP disclosed
WO-2008118427-A9 SYNTHESIS OF (S)-(+)-3-(AMINOMETHYL)-5-METHYL HEXANOIC ACID TEVA PHARMA (IL) 2009-02-05 WO disclosed
WO-2008118427-A2 SYNTHESIS OF (S)-(+)-3-(AMINOMETHYL)-5-METHYL HEXANOIC ACID TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) 2008-10-02 WO disclosed
EP-1841726-A1 AN ASYMMETRIC SYNTHESIS OF ( S ) - ( + ) -3- (AMINOMETHYL) -5-METHYLHEXANOIC ACID Teva Pharmaceutical Industries Ltd (IL) 2007-10-10 EP disclosed
WO-2007035890-A1 AN ASYMMETRIC SYNTHESIS OF ( S ) - ( + ) -3- (AMINOMETHYL) -5-METHYLHEXANOIC ACID TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) 2007-03-29 WO disclosed